Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy decision coaching for people with multiple sclerosis - Implementation of an interprofessional decision support programme into clinical practice.

Multiple sclerosis and related disorders·2026
Same author

Biological Age Affecting Attrition and Tooth Loss in a Follow-up Study.

Journal of dental research·2024
Same author

Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].

Patient education and counseling·2024
Same author

Rapid differentiation of MOGAD and MS after a single optic neuritis.

Journal of neurology·2024
Same author

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation.

Patient education and counseling·2024
Same author

Adherence coaching is not shared-decision making!

Multiple sclerosis and related disorders·2024

Related Experiment Video

Updated: Feb 28, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning

J P Stellmann1, K L Young1, J Pöttgen1

  • 1Institute of Neuroimmunology and MS (INIMS), University Medical Centre Hamburg-Eppendorf, Germany.

Multiple Sclerosis Journal - Experimental, Translational and Clinical
|June 14, 2017
PubMed
Summary

The quick contrast-sensitivity function (qCSF) shows a stronger link to patient-reported visual function in multiple sclerosis (MS) than standard charts. This new method offers a promising way to assess low-contrast vision in neurological diseases.

Keywords:
Outcome measurementSloan chartscontrast visionmultiple sclerosisvisual acuity

More Related Videos

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

1000
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.4K

Related Experiment Videos

Last Updated: Feb 28, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.8K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

1000
Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
07:11

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping

Published on: December 8, 2023

2.4K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Medical Imaging

Background:

  • Impaired low-contrast visual acuity (LCVA) is a common issue in multiple sclerosis (MS) and other neurological conditions.
  • Current assessments of LCVA often use limited contrast levels (e.g., 2.5%, 1.25%).
  • Computerized adaptive testing, such as the quick contrast-sensitivity function (qCSF), enables evaluation across a wider range of contrasts and spatial frequencies.

Purpose of the Study:

  • To compare the qCSF method with traditional high-contrast visual acuity (HCVA) and low-contrast charts.
  • To evaluate the association between qCSF and patient-reported visual function using the National Eye Institute Visual Functioning Questionnaire (NEIVFQ).

Main Methods:

  • 131 consecutive MS patients were enrolled.
  • Assessments included HCVA (at 30cm and 5m), low-contrast vision (Sloan charts at 2.5% and 1.25%), qCSF, and the NEIVFQ.
  • Linear regression models, corrected for age, gender, and multiple testing, were used to analyze associations.

Main Results:

  • qCSF demonstrated a higher association with Sloan charts (R²=0.68) compared to HCVA (5m: R²=0.5; 30cm: R²=0.41).
  • qCSF showed the strongest association with NEIVFQ subscales (R²=0.20-0.57).
  • Sloan charts lacked significant association with NEIVFQ subscales after multiple testing correction.

Conclusions:

  • The qCSF method is a valuable and promising outcome measure for assessing low-contrast vision in MS and other neurological disorders.
  • qCSF exhibits a stronger correlation with patient-reported visual function compared to standard low- and high-contrast charts.